Dental service organization, Pacific Smiles Group (ASX: PSQ), reported its financial results for the fiscal year ending June 30, 2023. The company's focus on operational efficiency and increased chair utilization in the post-pandemic period led to substantial growth. Patient fees surged by 19.5% to AU$270.5 million compared to the prior year, supported by a 14.9% increase in same-center patient fees.
Group revenue rose by 18.5% to AU$165.3 million year-on-year, driving underlying EBITDA up by 113.9% to AU$24.1 million. Pacific Smiles achieved a significant turnaround, reporting an underlying NPAT of AU$4.5 million after a net loss of AU$3.2 million in the previous year. This growth allowed the company to resume a final dividend of 2.27 cents per share, totaling 2.62 cents per share for FY23. The company's strategy of optimizing existing centers and controlling costs contributed to the improved financial outcomes.
Customer Notice:
Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.
Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com
Nov 21, 2024
Nov 21, 2024
Nov 21, 2024
Nov 21, 2024
Nov 21, 2024
Nov 21, 2024
Nov 21, 2024
Nov 21, 2024
Nov 20, 2024
Nov 20, 2024
Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.
